Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

EXPLORING THE MECHANISM OF METASTASIS/DEVELOPMENT OF NEW TESTS TO ENROLL CIRCULATING TUMOR CELLS (CTCs) INTO CLINICAL PRACTICE

Project description

Advancing liquid biopsies for precision cancer care

Cancer is one of the major causes of mortality worldwide, and there is an urgent need for improved detection of disease progression and response to treatment. Supported by the Marie Skłodowska-Curie Actions programme, the CTC4CLINIC project is designing and testing liquid biopsy platforms using circulating tumour cells (CTCs). It will use genomics, epigenomics, transcriptomics, live-cell imaging and AI to increase knowledge of metastasis and the evolution of cancers. The project will also create very sensitive standardised assays and clinical protocols to diagnose and monitor patients with breast, prostate, lung, and pancreatic cancers.

Objective

CTC4CLINIC is an innovative project, aims to improve cancer diagnosis and monitoring by developing and validating innovative liquid biopsy assays based on circulating tumor cells (CTCs). These tumor cells, found in the blood of cancer patients, are important prognostic factors. They also hold significant information for tumor behavior, disease evolution, and treatment response. However, they are not yet widely used in clinical practice due to their rarity and the difficulties in their isolation and characterization.
This project brings together experts from universities, hospitals, and private laboratories across Europe and the United States. It will combine different scientific approaches, including biochemistry, analytical chemistry, single-cell sequencing, spatial transcriptomics, live-cell imaging, and artificial intelligence, to better understand how tumors spread and evolve. A key innovation is the simultaneous analysis of CTCs in genomic, epigenomic, transcriptomic, and functional levels from the same patient sample, improving the sensitivity and reliability of liquid biopsy tools.
Therefore, the objectives of the current project are:
1. Elucidate the mechanistic role of CTCs in metastatic dissemination.
2. Develop standardized, highly sensitive, combined molecular and functional assays for CTC analysis.
3. Build a harmonized pipeline for clinical translation through intersectoral secondments, ensuring reproducibility and protocol standardization across partner institutions.
4. Provide advanced training for researchers, fostering transferable skills and accelerating the pathway from discovery to commercialization.
This staff exchange project will support the development of standardized protocols and the clinical validation of new diagnostic tools for patients with breast, prostate, lung, and pancreatic cancers.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-SE - HORIZON TMA MSCA Staff Exchanges

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-SE-01

See all projects funded under this call

Coordinator

PANEPISTIMIO PATRON
Net EU contribution
€ 225 450,00
Address
UNIVERSITY CAMPUS RIO PATRAS
265 04 RIO PATRAS
Greece
Region
Κεντρική Ελλάδα Δυτική Ελλάδα Αχαΐα
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Participants (8)

Partners (3)